EOLS
Evolus, Inc.
Drug Manufacturers - Specialty & Generic
Market Cap$421M
5Y Perf.-29.9%
Compare Stocks
4 / 10Try these comparisons:
Stock Comparison
EOLS vs AVAH vs ABBV vs PNTG
Revenue, margins, valuation, and 5-year total return — side by side.
AVAH
Aveanna Healthcare Holdings Inc.
Medical - Care Facilities
Market Cap$1.46B
5Y Perf.-40.6%
ABBV
AbbVie Inc.
Drug Manufacturers - General
Market Cap$358.42B
5Y Perf.+81.7%
PNTG
The Pennant Group, Inc.
Medical - Care Facilities
Market Cap$1.24B
5Y Perf.-11.6%
EOLS vs AVAH vs ABBV vs PNTG — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | EOLS | AVAH | ABBV | PNTG |
|---|---|---|---|---|
| Industry | Drug Manufacturers - Specialty & Generic | Medical - Care Facilities | Drug Manufacturers - General | Medical - Care Facilities |
| Market Cap | $421M | $1.46B | $358.42B | $1.24B |
| Revenue (TTM) | $301M | $2.43B | $61.16B | $1.02B |
| Net Income (TTM) | $-43M | $225M | $4.23B | $30M |
| Gross Margin | 65.7% | 33.1% | 70.2% | 11.1% |
| Operating Margin | -9.6% | 10.9% | 26.7% | 5.6% |
| Forward P/E | — | 12.0x | 14.3x | 27.0x |
| Total Debt | $155M | $1.34B | $69.07B | $453M |
| Cash & Equiv. | $54M | $193M | $5.23B | $17M |
EOLS vs AVAH vs ABBV vs PNTG — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
EOLS
AVAH
ABBV
PNTG
| Stock | Apr 21 | May 26 | Return |
|---|---|---|---|
| Evolus, Inc. (EOLS) | 100 | 70.1 | -29.9% |
| Aveanna Healthcare … (AVAH) | 100 | 59.4 | -40.6% |
| AbbVie Inc. (ABBV) | 100 | 181.7 | +81.7% |
| The Pennant Group, … (PNTG) | 100 | 88.4 | -11.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: EOLS vs AVAH vs ABBV vs PNTG
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: AVAH leads in 4 of 7 categories, making it the strongest pick for valuation and capital efficiency and profitability and margin quality. AbbVie Inc. is the stronger pick specifically for capital preservation and lower volatility and dividend income and shareholder returns. PNTG also leads in specific categories worth noting. As sector peers, any of these can serve as alternatives in the same allocation.
EOLS
Evolus, Inc.
The Defensive Pick
EOLS is the clearest fit if your priority is defensive.
- Beta 1.27, current ratio 1.90x
Best for: defensive
AVAH
Aveanna Healthcare Holdings Inc.
The Value Play
AVAH carries the broadest edge in this set and is the clearest fit for value and quality.
- Lower P/E (12.0x vs 27.0x)
- 9.2% margin vs EOLS's -14.4%
- +44.0% vs EOLS's -45.7%
- 12.4% ROA vs EOLS's -19.4%, ROIC 15.1% vs -44.5%
Best for: value and quality
ABBV
AbbVie Inc.
The Income Pick
ABBV is the #2 pick in this set and the best alternative if income & stability and long-term compounding is your priority.
- Dividend streak 13 yrs, beta 0.34, yield 3.2%
- 295.5% 10Y total return vs PNTG's 136.8%
- Beta 0.34 vs AVAH's 1.40
- 3.2% yield; 13-year raise streak; the other 3 pay no meaningful dividend
Best for: income & stability and long-term compounding
PNTG
The Pennant Group, Inc.
The Growth Play
PNTG is the clearest fit if your priority is growth exposure and sleep-well-at-night.
- Rev growth 36.3%, EPS growth 18.3%, 3Y rev CAGR 26.0%
- Lower volatility, beta 0.79, current ratio 1.14x
- 36.3% revenue growth vs ABBV's 8.6%
Best for: growth exposure and sleep-well-at-night
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | PNTG | 36.3% revenue growth vs ABBV's 8.6% |
| Value | AVAH | Lower P/E (12.0x vs 27.0x) |
| Quality / Margins | AVAH | 9.2% margin vs EOLS's -14.4% |
| Stability / Safety | ABBV | Beta 0.34 vs AVAH's 1.40 |
| Dividends | ABBV | 3.2% yield; 13-year raise streak; the other 3 pay no meaningful dividend |
| Momentum (1Y) | AVAH | +44.0% vs EOLS's -45.7% |
| Efficiency (ROA) | AVAH | 12.4% ROA vs EOLS's -19.4%, ROIC 15.1% vs -44.5% |
EOLS vs AVAH vs ABBV vs PNTG — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
FY 2025
FY 2025
FY 2025
FY 2025
EOLS vs AVAH vs ABBV vs PNTG — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLABBVLAGGINGPNTG
Who Leads Where
ABBV leads in 3 of 6 categories
AVAH leads 2 • EOLS leads 0 • PNTG leads 0 • 1 tied
Explore the data ↓PNTGThe Pennant Group, In…
0leads
EOLSEvolus, Inc.
0leads
AVAHAveanna Healthcare Ho…
2leads
ABBVAbbVie Inc.
3leads
6 Total Categories
CATEGORYLEADERvs AVAHvs EOLSMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
ABBV4/6
Valuation MetricsMultiples, price ratios, and targets
AVAH4/6
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
ABBV4/9
Total Returns1Y, 3Y, 5Y total returns with dividends
AVAH3/6
Risk & VolatilityBeta, volatility, and downside exposure
Tied
—
Analyst OutlookRatings, price targets, and dividends
ABBV1/1
Income & Cash Flow (Last 12 Months)
ABBV leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ABBV is the larger business by revenue, generating $61.2B annually — 202.9x EOLS's $301M. AVAH is the more profitable business, keeping 9.2% of every revenue dollar as net income compared to EOLS's -14.4%. On growth, PNTG holds the edge at +36.0% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | EOLSEvolus, Inc. | AVAHAveanna Healthcar… | ABBVAbbVie Inc. | PNTGThe Pennant Group… |
|---|---|---|---|---|
| RevenueTrailing 12 months | $301M | $2.4B | $61.2B | $1.0B |
| EBITDAEarnings before interest/tax | -$21M | $289M | $24.5B | $66M |
| Net IncomeAfter-tax profit | -$43M | $225M | $4.2B | $30M |
| Free Cash FlowCash after capex | -$41M | $126M | $18.7B | $47M |
| Gross MarginGross profit ÷ Revenue | +65.7% | +33.1% | +70.2% | +11.1% |
| Operating MarginEBIT ÷ Revenue | -9.6% | +10.9% | +26.7% | +5.6% |
| Net MarginNet income ÷ Revenue | -14.4% | +9.2% | +6.9% | +3.0% |
| FCF MarginFCF ÷ Revenue | -13.7% | +5.2% | +30.6% | +4.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | +6.2% | +27.4% | +10.0% | +36.0% |
| EPS Growth (YoY)Latest quarter vs prior year | +46.7% | +4.9% | +57.4% | +9.1% |
ABBV leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
AVAH leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
At 6.6x trailing earnings, AVAH trades at a 92% valuation discount to ABBV's 85.5x P/E. On an enterprise value basis, AVAH's 9.0x EV/EBITDA is more attractive than PNTG's 28.0x.
| Metric | EOLSEvolus, Inc. | AVAHAveanna Healthcar… | ABBVAbbVie Inc. | PNTGThe Pennant Group… |
|---|---|---|---|---|
| Market CapShares × price | $421M | $1.5B | $358.4B | $1.2B |
| Enterprise ValueMkt cap + debt − cash | $522M | $2.6B | $422.3B | $1.7B |
| Trailing P/EPrice ÷ TTM EPS | -7.99x | 6.61x | 85.50x | 42.54x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 11.96x | 14.28x | 26.97x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | 4.23x |
| EV / EBITDAEnterprise value multiple | — | 9.04x | 14.96x | 27.97x |
| Price / SalesMarket cap ÷ Revenue | 1.42x | 0.60x | 5.86x | 1.31x |
| Price / BookPrice ÷ Book value/share | — | 7.67x | — | 3.37x |
| Price / FCFMarket cap ÷ FCF | — | 11.63x | 20.12x | 47.16x |
AVAH leads this category, winning 4 of 6 comparable metrics.
Profitability & Efficiency
ABBV leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
ABBV delivers a 62.1% return on equity — every $100 of shareholder capital generates $62 in annual profit, vs $8 for PNTG. PNTG carries lower financial leverage with a 1.21x debt-to-equity ratio, signaling a more conservative balance sheet compared to AVAH's 6.91x. On the Piotroski fundamental quality scale (0–9), AVAH scores 6/9 vs PNTG's 3/9, reflecting solid financial health.
| Metric | EOLSEvolus, Inc. | AVAHAveanna Healthcar… | ABBVAbbVie Inc. | PNTGThe Pennant Group… |
|---|---|---|---|---|
| ROE (TTM)Return on equity | — | +9.5% | +62.1% | +8.4% |
| ROA (TTM)Return on assets | -19.4% | +12.4% | +3.1% | +3.5% |
| ROICReturn on invested capital | -44.5% | +15.1% | +23.9% | +5.6% |
| ROCEReturn on capital employed | -23.5% | +18.6% | +21.5% | +7.3% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 6 | 6 | 3 |
| Debt / EquityFinancial leverage | — | 6.91x | — | 1.21x |
| Net DebtTotal debt minus cash | $101M | $1.2B | $63.8B | $436M |
| Cash & Equiv.Liquid assets | $54M | $193M | $5.2B | $17M |
| Total DebtShort + long-term debt | $155M | $1.3B | $69.1B | $453M |
| Interest CoverageEBIT ÷ Interest expense | -1.92x | 1.79x | 3.28x | 16.52x |
ABBV leads this category, winning 4 of 9 comparable metrics.
Total Returns (Dividends Reinvested)
AVAH leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ABBV five years ago would be worth $20,131 today (with dividends reinvested), compared to $6,019 for AVAH. Over the past 12 months, AVAH leads with a +44.0% total return vs EOLS's -45.7%. The 3-year compound annual growth rate (CAGR) favors AVAH at 89.5% vs EOLS's -10.6% — a key indicator of consistent wealth creation.
| Metric | EOLSEvolus, Inc. | AVAHAveanna Healthcar… | ABBVAbbVie Inc. | PNTGThe Pennant Group… |
|---|---|---|---|---|
| YTD ReturnYear-to-date | -4.9% | -14.1% | -10.1% | +28.4% |
| 1-Year ReturnPast 12 months | -45.7% | +44.0% | +11.3% | +28.7% |
| 3-Year ReturnCumulative with dividends | -28.4% | +580.4% | +50.4% | +204.1% |
| 5-Year ReturnCumulative with dividends | -30.1% | -39.8% | +101.3% | -6.9% |
| 10-Year ReturnCumulative with dividends | -44.4% | -42.2% | +295.5% | +136.8% |
| CAGR (3Y)Annualised 3-year return | -10.6% | +89.5% | +14.6% | +44.9% |
AVAH leads this category, winning 3 of 6 comparable metrics.
Risk & Volatility
Evenly matched — ABBV and PNTG each lead in 1 of 2 comparable metrics.
Risk & Volatility
ABBV is the less volatile stock with a 0.34 beta — it tends to amplify market swings less than AVAH's 1.40 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. PNTG currently trades 99.7% from its 52-week high vs EOLS's 52.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | EOLSEvolus, Inc. | AVAHAveanna Healthcar… | ABBVAbbVie Inc. | PNTGThe Pennant Group… |
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.27x | 1.40x | 0.34x | 0.79x |
| 52-Week HighHighest price in past year | $12.16 | $10.32 | $244.81 | $35.84 |
| 52-Week LowLowest price in past year | $3.86 | $3.73 | $176.57 | $21.73 |
| % of 52W HighCurrent price vs 52-week peak | +52.5% | +67.2% | +82.8% | +99.7% |
| RSI (14)Momentum oscillator 0–100 | 76.1 | 53.4 | 46.8 | 62.5 |
| Avg Volume (50D)Average daily shares traded | 1.1M | 1.1M | 5.8M | 245K |
Evenly matched — ABBV and PNTG each lead in 1 of 2 comparable metrics.
Analyst Outlook
ABBV leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: EOLS as "Buy", AVAH as "Hold", ABBV as "Buy", PNTG as "Buy". Consensus price targets imply 134.7% upside for EOLS (target: $15) vs 9.2% for PNTG (target: $39). ABBV is the only dividend payer here at 3.24% yield — a key consideration for income-focused portfolios.
| Metric | EOLSEvolus, Inc. | AVAHAveanna Healthcar… | ABBVAbbVie Inc. | PNTGThe Pennant Group… |
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Buy | Buy |
| Price TargetConsensus 12-month target | $15.00 | $11.00 | $256.64 | $39.00 |
| # AnalystsCovering analysts | 13 | 12 | 41 | 7 |
| Dividend YieldAnnual dividend ÷ price | — | — | +3.2% | — |
| Dividend StreakConsecutive years of raises | — | — | 13 | 1 |
| Dividend / ShareAnnual DPS | — | — | $6.57 | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | +0.3% | 0.0% |
ABBV leads this category, winning 1 of 1 comparable metric.
Key Takeaway
ABBV leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). AVAH leads in 2 (Valuation Metrics, Total Returns). 1 tied.
Best OverallAbbVie Inc. (ABBV)Leads 3 of 6 categories
Loading custom metrics...
EOLS vs AVAH vs ABBV vs PNTG: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is EOLS or AVAH or ABBV or PNTG a better buy right now?
For growth investors, The Pennant Group, Inc.
(PNTG) is the stronger pick with 36. 3% revenue growth year-over-year, versus 8. 6% for AbbVie Inc. (ABBV). Aveanna Healthcare Holdings Inc. (AVAH) offers the better valuation at 6. 6x trailing P/E (12. 0x forward), making it the more compelling value choice. Analysts rate Evolus, Inc. (EOLS) a "Buy" — based on 13 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — EOLS or AVAH or ABBV or PNTG?
On trailing P/E, Aveanna Healthcare Holdings Inc.
(AVAH) is the cheapest at 6. 6x versus AbbVie Inc. at 85. 5x. On forward P/E, Aveanna Healthcare Holdings Inc. is actually cheaper at 12. 0x.
03Which is the better long-term investment — EOLS or AVAH or ABBV or PNTG?
Over the past 5 years, AbbVie Inc.
(ABBV) delivered a total return of +101. 3%, compared to -39. 8% for Aveanna Healthcare Holdings Inc. (AVAH). Over 10 years, the gap is even starker: ABBV returned +295. 5% versus EOLS's -44. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — EOLS or AVAH or ABBV or PNTG?
By beta (market sensitivity over 5 years), AbbVie Inc.
(ABBV) is the lower-risk stock at 0. 34β versus Aveanna Healthcare Holdings Inc. 's 1. 40β — meaning AVAH is approximately 314% more volatile than ABBV relative to the S&P 500. On balance sheet safety, The Pennant Group, Inc. (PNTG) carries a lower debt/equity ratio of 121% versus 7% for Aveanna Healthcare Holdings Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — EOLS or AVAH or ABBV or PNTG?
By revenue growth (latest reported year), The Pennant Group, Inc.
(PNTG) is pulling ahead at 36. 3% versus 8. 6% for AbbVie Inc. (ABBV). On earnings-per-share growth, the picture is similar: Aveanna Healthcare Holdings Inc. grew EPS 1952% year-over-year, compared to -0. 8% for AbbVie Inc.. Over a 3-year CAGR, PNTG leads at 26. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — EOLS or AVAH or ABBV or PNTG?
Aveanna Healthcare Holdings Inc.
(AVAH) is the more profitable company, earning 9. 2% net margin versus -17. 4% for Evolus, Inc. — meaning it keeps 9. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ABBV leads at 32. 8% versus -12. 7% for EOLS. At the gross margin level — before operating expenses — ABBV leads at 70. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is EOLS or AVAH or ABBV or PNTG more undervalued right now?
On forward earnings alone, Aveanna Healthcare Holdings Inc.
(AVAH) trades at 12. 0x forward P/E versus 27. 0x for The Pennant Group, Inc. — 15. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for EOLS: 134. 7% to $15. 00.
08Which pays a better dividend — EOLS or AVAH or ABBV or PNTG?
In this comparison, ABBV (3.
2% yield) pays a dividend. EOLS, AVAH, PNTG do not pay a meaningful dividend and should not be held primarily for income.
09Is EOLS or AVAH or ABBV or PNTG better for a retirement portfolio?
For long-horizon retirement investors, AbbVie Inc.
(ABBV) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 34), 3. 2% yield, +295. 5% 10Y return). Both have compounded well over 10 years (ABBV: +295. 5%, AVAH: -42. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between EOLS and AVAH and ABBV and PNTG?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: EOLS is a small-cap quality compounder stock; AVAH is a small-cap high-growth stock; ABBV is a large-cap income-oriented stock; PNTG is a small-cap high-growth stock. ABBV pays a dividend while EOLS, AVAH, PNTG do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
Revenue Growth>
%
(EOLS: 6.2% · AVAH: 27.4%)You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.